#Endoscope Reprocessing Device Market Share

[pranjaldalvi]

Disposable Endoscopes Market: Emerging Trends Shaping Future Medical Practices

The disposable endoscopes market is rapidly gaining traction within the medical device industry, driven by the increasing demand for cost-effective, safe, and infection-free diagnostic and surgical procedures. Unlike traditional reusable endoscopes, disposable variants offer single-use functionality, eliminating the risk of cross-contamination and reducing the need for complex reprocessing. This market has witnessed significant evolution due to technological innovations, rising healthcare awareness, and growing regulatory support, positioning itself as a transformative force in modern medical diagnostics and treatment.

Market Overview

Disposable endoscopes are being widely adopted across various medical specialties including urology, pulmonology, gastroenterology, and otolaryngology. With healthcare providers under constant pressure to enhance patient safety and streamline operational efficiency, single-use devices have emerged as a practical solution. The demand is particularly high in outpatient settings, emergency rooms, and intensive care units, where rapid turnaround and infection prevention are top priorities.

The global market size for disposable endoscopes has been growing steadily and is expected to continue on an upward trajectory. This growth is largely attributed to the increasing prevalence of hospital-acquired infections, the rising geriatric population, and a broader shift toward value-based healthcare models.

Key Emerging Trends

1. Integration of Smart Technologies

One of the most influential trends in the disposable endoscopes market is the integration of smart and digital technologies. Many new devices now feature advanced imaging capabilities such as high-definition visualization, real-time data transmission, and AI-assisted diagnostics. These innovations are enhancing clinical outcomes by improving diagnostic accuracy and procedure efficiency.

2. Expansion into New Specialties

Initially concentrated in urology and bronchoscopy, disposable endoscopes are now finding applications in other fields such as gastrointestinal endoscopy and ENT (ear, nose, and throat) diagnostics. As manufacturers refine designs to suit the unique needs of each specialty, the scope of application is expanding, bringing with it a broader customer base.

3. Regulatory Momentum and Guidelines

Regulatory agencies around the world are increasingly acknowledging the safety advantages of disposable medical devices. Guidelines promoting single-use endoscopes to reduce infection risks have bolstered their adoption. This regulatory backing has encouraged hospitals to invest more in these devices, especially in high-risk procedures and vulnerable patient populations.

4. Cost-Benefit Analysis Favoring Single-Use

While disposable endoscopes might seem costlier per unit compared to reusable ones, they eliminate hidden costs associated with cleaning, maintenance, repair, and sterilization. Studies and internal hospital audits have begun to reveal the long-term economic advantages of adopting single-use endoscopes, especially when factoring in litigation risks and costs of treating infections.

5. Sustainability Concerns and Eco-Friendly Initiatives

A growing concern with disposable medical devices is environmental sustainability. However, recent advancements have seen the development of recyclable materials and eco-friendly disposal solutions. Companies are increasingly focusing on designing biodegradable or low-impact devices to align with healthcare institutions' environmental goals.

Competitive Landscape

The disposable endoscopes market is highly competitive, with both established medical device giants and innovative startups vying for market share. Leading players are investing heavily in R&D to improve device performance, miniaturize components, and enhance user ergonomics. Strategic partnerships, mergers, and acquisitions are also common, as companies seek to broaden their product portfolios and gain competitive advantages.

Startups are contributing significantly by offering niche solutions with specialized functionalities, catering to underserved segments of the market. This has resulted in a dynamic ecosystem that fosters rapid innovation and responsiveness to clinical needs.

Regional Insights

North America currently holds a significant share of the global disposable endoscopes market, driven by stringent infection control protocols and advanced healthcare infrastructure. Europe follows closely, supported by favorable regulatory frameworks and rising healthcare expenditures. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth due to increasing healthcare access, a growing middle-class population, and expanding hospital networks in countries like China and India.

Future Outlook

The future of the disposable endoscopes market looks promising, with continuous improvements in materials science, imaging technology, and AI integration likely to revolutionize diagnostic and surgical procedures. As healthcare systems worldwide strive for improved outcomes, patient safety, and operational efficiency, the demand for single-use endoscopic devices is expected to rise further.

In the coming years, expect to see greater standardization, cost reduction through mass production, and deeper penetration into low- and middle-income countries. These trends, combined with a proactive regulatory environment and shifting clinical preferences, position the disposable endoscopes market as a pivotal component of the evolving global healthcare landscape.

[wellnesstribe]

Disposable Endoscopes Market Future Outlook Shows Increased Adoption Due To Infection Control And Cost Efficiency

The global healthcare industry continues to evolve, driven by the need for safer, more efficient, and cost-effective solutions. Among the innovations transforming modern medical practices is the increasing adoption of Disposable Endoscopes Market. These single-use devices are steadily gaining traction across various clinical applications, including bronchoscopy, urology, gastrointestinal (GI) procedures, and ENT (ear, nose, and throat) diagnostics.

Market Drivers and Growth Factors

The shift toward disposable endoscopes is largely driven by infection control concerns and the limitations of traditional reusable endoscopes. In recent years, several outbreaks of infection have been linked to improperly reprocessed endoscopes, despite rigorous cleaning protocols. Disposable endoscopes eliminate this risk by offering a sterile, ready-to-use option for each patient.

Additionally, technological advancements in materials, optics, and manufacturing have made disposable devices increasingly viable alternatives to their reusable counterparts. Today’s single-use endoscopes are more advanced, offering high-definition visualization, greater maneuverability, and ergonomic designs—all at lower costs.

Other key growth factors include:

Increasing number of minimally invasive procedures

Rising demand for outpatient and ambulatory care

Expanding aging population with chronic and degenerative diseases

Growing investments from medical device companies and venture capital firms

Segmental Analysis and Applications

The disposable endoscopes market is segmented based on type, application, end user, and geography. By type, bronchoscopes and urologic endoscopes are among the fastest-growing segments due to high procedure volumes and the critical need for sterility. In terms of applications, diagnostic procedures dominate due to the high frequency of use in detecting abnormalities and infections.

From an end-user perspective, hospitals and ambulatory surgical centers (ASCs) are leading adopters. ASCs, in particular, are pushing the demand for cost-effective, portable, and easily managed equipment that does not require specialized sterilization infrastructure.

Regional Trends

North America currently holds the largest market share, attributed to the region’s well-established healthcare infrastructure, favorable reimbursement policies, and heightened awareness of hospital-acquired infections (HAIs). Europe is also showing steady growth, particularly in countries like Germany and the UK, where healthcare regulations are increasingly emphasizing infection control.

However, Asia-Pacific is projected to experience the fastest growth, fueled by rising healthcare expenditure, government initiatives for modernizing medical equipment, and the expansion of private hospitals and diagnostic centers.

Challenges and Limitations

Despite strong growth potential, the disposable endoscopes market is not without challenges. Concerns around environmental sustainability are beginning to emerge, as the single-use nature of these devices contributes to medical waste. Manufacturers and healthcare providers are exploring recyclable materials and more sustainable disposal methods.

Another concern is the cost perception. While disposable endoscopes eliminate expenses related to reprocessing and maintenance, their upfront cost per use is still higher compared to amortized reusable devices. Educating hospitals and clinicians on the total cost of ownership (TCO)—including potential savings from infection prevention—is critical to increasing adoption.

Future Outlook

Looking ahead, the disposable endoscopes market is expected to witness robust CAGR through 2030. This growth will be shaped by continued innovations, growing preference for outpatient procedures, and regulatory shifts favoring infection prevention. As hospitals and healthcare systems seek greater efficiency without compromising patient safety, disposable endoscopes will increasingly become standard practice.

To sustain this growth, industry players must focus on affordability, environmental responsibility, and clinical performance. The future holds promise not just in high-income regions but also in emerging economies where healthcare access and infrastructure are rapidly advancing.

[farmacuticals]

Exploring the Algae Supplements Market: Key Drivers and Emerging Opportunities

An Automated Endoscopy Reprocessor (AER) is a specialized machine designed to disinfect and sterilize endoscopes and other flexible medical instruments, providing an efficient and reliable alternative to manual cleaning. As the demand for endoscopic procedures has increased due to rising cases of gastrointestinal, respiratory, and urinary diseases, the importance of safe, efficient reprocessing methods like Automated Endoscopy Reprocessors has grown. AERs ensure that the devices are disinfected according to high medical standards, reducing the risk of cross-contamination and infection between procedures. These systems offer consistent, controlled cleaning cycles that minimize human error, helping healthcare facilities adhere to strict infection control guidelines.

The Automated Endoscopy Reprocessor Market Size was projected to reach 1.36 billion USD in 2022, according to MRFR analysis. By 2032, the market for automated endoscopy reprocessors is projected to have grown from 1.47 billion USD in 2023 to 2.8 billion USD. During the projected period (2024-2032), the Automated Endoscopy Reprocessor Market is anticipated to grow at a CAGR of approximately 7.45%.

Automated Endoscopy Reprocessor Size and Market Share

The Automated Endoscopy Reprocessor market has seen steady growth in recent years, reflecting the expanding usage of endoscopic procedures globally. Market size is influenced by several factors, including healthcare providers’ focus on infection prevention, advancements in healthcare infrastructure, and the growing awareness about patient safety. In terms of market share, leading manufacturers such as Olympus, Medivators, and Getinge have dominated the market due to their advanced product offerings and established distribution networks. However, the market also includes new entrants bringing innovative solutions to Automated Endoscopy Reprocessor technology, contributing to the market’s size and competitive landscape. The demand for compact, space-saving models has also increased, particularly in smaller healthcare facilities where space constraints are a concern.

Automated Endoscopy Reprocessor Analysis

Analyzing the Automated Endoscopy Reprocessor market involves looking at current trends, regulatory factors, technological advancements, and the regional demands that shape its growth. Technological advancements such as touchscreen interfaces, automated reporting, and reduced cycle times are significant drivers. Additionally, compliance with regulatory bodies like the FDA and ISO is crucial, as these organizations set stringent standards for disinfection processes to ensure patient safety. Regional factors also play a role; for instance, the North American market has seen a high adoption rate due to stringent healthcare regulations, while emerging markets in Asia-Pacific are expected to see growth due to increased healthcare investments and rising awareness of infection control practices.

Automated Endoscopy Reprocessor Trends

Several key trends are currently shaping the Automated Endoscopy Reprocessor market. Firstly, there is a growing demand for eco-friendly and energy-efficient systems as healthcare providers look to reduce their environmental impact. Secondly, automated data tracking and digital connectivity have become more prevalent, allowing facilities to monitor and document disinfection cycles for compliance purposes. Thirdly, the shift toward single-use devices in some regions impacts the AER market, although reusable devices remain prevalent in many areas due to cost efficiency. Additionally, there is an increased focus on user-friendly interfaces and quick turnaround times, which help improve workflow efficiency in busy healthcare settings. These trends indicate a movement toward smarter, safer, and more efficient disinfection systems.

Reasons to Buy the Reports

Gain comprehensive insights into the Automated Endoscopy Reprocessor market, including market size, share, and key growth drivers.

Understand the latest Automated Endoscopy Reprocessor trends, from technological advancements to regulatory factors that influence purchasing decisions.

Access detailed Automated Endoscopy Reprocessor analysis, helping stakeholders make informed investment and strategy decisions.

Learn about recent developments and innovations in the AER market, including environmentally friendly options and smart connectivity features.

Benchmark leading players and assess potential new entrants to understand competitive dynamics in the Automated Endoscopy Reprocessor landscape.

Recent Developments in the Automated Endoscopy Reprocessor Market

Recent advancements in the Automated Endoscopy Reprocessor market include the introduction of devices that support rapid cycle times, allowing for quicker patient turnover in busy healthcare environments. Companies are also focusing on the development of AER systems with integrated data logging and remote monitoring capabilities, which allow facilities to track reprocessing data in real-time and ensure compliance with regulations. Additionally, manufacturers have responded to market demands for compact models that fit smaller facilities without compromising on performance. Sustainability has been another area of focus, with companies like Getinge releasing AER models that use lower amounts of water and chemicals, reducing the overall environmental impact of the reprocessing process. These advancements indicate an ongoing trend toward efficient, eco-friendly, and data-centric reprocessing solutions that cater to the needs of modern healthcare facilities.

In summary, the Automated Endoscopy Reprocessor market is evolving to meet the increasing demand for safe, effective, and efficient disinfection solutions, driven by trends in digital connectivity, environmental sustainability, and enhanced performance.

Relate reports:

pelvic floor stimulator market

pharmaceutical solvent market

plastic surgery instrument market

Top of Form

Bottom of Form

[industrynewsupdates]

Type Insights: How the Infection Control Market is Adapting to New Challenges

The global infection control market was valued at USD 214.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This growth is primarily driven by the rising number of surgical and clinical procedures that necessitate stringent infection prevention measures. The increasing preference for infection control solutions is largely attributed to the favorable clinical outcomes associated with their use. Additionally, the COVID-19 pandemic has positively influenced market growth, as the demand for sterilization and disinfection has surged in hospitals, clinics, and among pharmaceutical and medical device companies.

During the pandemic, the production of sanitizer products saw a remarkable 60% increase in the U.S. alone, highlighting the substantial growth potential for infection control products in the future. Furthermore, the trend of outsourcing sterilization services and the introduction of advanced sterilization solutions are contributing to the market's expansion. A significant driver of growth is the increasing number of government initiatives aimed at ensuring robust infection prevention measures. Governments worldwide are increasingly involved in issuing guidelines to promote awareness and effective prevention strategies, which is expected to support market growth throughout the forecast period. For instance, the World Health Organization (WHO) has provided guidelines to prevent and control pandemic- and epidemic-prone acute respiratory diseases in healthcare settings, covering essential practices such as hand hygiene, the use of personal protective equipment (PPE), and disinfection and sterilization protocols.

Gather more insights about the market drivers, restrains and growth of the Infection Control Market

Type Insights

The global infection control market is segmented into three main categories: equipment, services, and consumables. In 2022, the consumables segment dominated the market, capturing the largest revenue share. This dominant position is largely due to the frequent use and short life cycle of consumable products, which are integral to disinfection, sterilization, and other infection control procedures. Consumables include items such as personal protective equipment (PPE), which held a significant share of the market as of 2022.

The equipment segment is further divided into disinfectors and sterilization equipment. Disinfectors are classified into washers, flushes, and endoscope reprocessors. The sterilization equipment category includes heat sterilization equipment, low-temperature sterilization equipment, radiation sterilization equipment, filtration sterilization equipment, and liquid sterilization equipment. Additionally, the consumables segment encompasses infectious waste disposal, disinfectants, sterilization consumables, and PPE, among others.

Various healthcare organizations are actively promoting awareness about the benefits of personal protective equipment, which is anticipated to contribute significantly to the market's growth. For example, W&H Company is enhancing its hygiene portfolio by introducing the LEXA PLUS CLASS B sterilizer, a technologically advanced device designed to streamline reprocessing and enhance infection prevention in dental practices.

Among the different segments, the services category is expected to experience the fastest CAGR during the forecast period. This rapid growth can be attributed to the increasing inclination of market players to reduce overall healthcare costs while capitalizing on the advantages that come with outsourcing. These advantages include cost savings, enhanced service efficiency, improved productivity, and a heightened focus on core developmental areas that are critical to a company's profitability and growth. Organizations also aim to promote the adoption of infection control services by issuing guidelines and recommendations regarding selection, risk assessment, rational usage, and disposal, all aimed at reducing the risk of transmitting respiratory pathogens within healthcare facilities. The services segment includes contract sterilization and infectious waste disposal, with the contract sterilization category further divided into methods such as ethylene oxide sterilization, e-beam sterilization, gamma sterilization, and other techniques.

Overall, the infection control market is positioned for substantial growth, driven by a combination of increasing healthcare needs, government initiatives, and advancements in technology and services.

Order a free sample PDF of the Infection Control Market Intelligence Study, published by Grand View Research.

[credenceresearchdotblog]

The global demand for Single Use Flexible Endoscope was valued at USD 1214.8 Million in 2022 and is expected to reach USD 7012.2 Million in 2030, growing at a CAGR of 24.50% between 2023 and 2030.In the rapidly evolving medical device landscape, single-use flexible endoscopes have emerged as a pivotal innovation. These devices offer significant benefits over reusable counterparts, particularly in terms of infection control, cost-efficiency, and operational convenience. The market for single-use flexible endoscopes has been expanding, driven by technological advancements and an increasing emphasis on patient safety and hygiene. This article delves into the current state of the single-use flexible endoscope market, its growth drivers, challenges, and future outlook.

Browse the full report at https://www.credenceresearch.com/report/single-use-flexible-endoscope-market

Market Overview

Single-use flexible endoscopes are designed for one-time use and then disposed of, eliminating the need for reprocessing and sterilization. This model addresses key issues associated with reusable endoscopes, including cross-contamination and the high costs of maintenance and sterilization. The market for these endoscopes has seen substantial growth due to their inherent advantages, such as reduced risk of infection, convenience, and enhanced performance consistency.

Growth Drivers

1. Infection Control and Patient Safety: One of the primary drivers for the adoption of single-use flexible endoscopes is the heightened focus on infection control. Reusable endoscopes have been associated with outbreaks of healthcare-associated infections (HAIs) due to difficulties in achieving complete sterilization. Single-use endoscopes mitigate this risk by eliminating the need for complex reprocessing.

2. Technological Advancements: Advances in endoscopic technology have led to the development of high-quality single-use endoscopes that offer comparable performance to reusable models. Innovations in materials and design have improved image quality, flexibility, and overall functionality, making these devices suitable for a wide range of medical applications.

3. Cost Efficiency: While the upfront cost of single-use endoscopes may be higher than that of reusable devices, they offer long-term cost savings. The elimination of reprocessing costs, repair expenses, and the need for sterilization facilities contribute to a more cost-effective solution in the long run.

4. Regulatory Support: The increasing regulatory support for single-use medical devices has further fueled market growth. Regulatory agencies are recognizing the benefits of single-use endoscopes in enhancing patient safety, which has led to faster approvals and greater acceptance in the healthcare community.

Challenges

Despite their advantages, single-use flexible endoscopes face several challenges:

1. Environmental Concerns: The disposal of single-use endoscopes contributes to medical waste, raising environmental concerns. Efforts are being made to develop more eco-friendly materials and recycling programs to mitigate the environmental impact.

2. Cost of Innovation: The development and production of high-quality single-use endoscopes require significant investment in research and development. This can lead to higher costs for manufacturers, which may be passed on to healthcare providers and patients.

3. Market Penetration: In some regions, particularly where reusable endoscopes are deeply entrenched, the adoption of single-use endoscopes may face resistance due to established practices and cost concerns. Education and awareness are crucial in overcoming these barriers.

Future Outlook

The single-use flexible endoscope market is poised for continued growth, driven by ongoing advancements in technology, increasing emphasis on patient safety, and the need for cost-effective medical solutions. Manufacturers are likely to focus on innovation to address environmental concerns and enhance the functionality of these devices. As healthcare systems globally evolve, the adoption of single-use endoscopes is expected to become more widespread, offering enhanced safety and efficiency in medical procedures.

Key Players

Ambu A/S

Olympus America

Boston Scientific Corporation

Fujifilm Holdings Corporation

Neoscope Inc.

Coloplast Corp

Laborie

Shenzhen Tianlang Medical

Intesurgical

Teleflex Incorporated

Segmentation

By Specialty:

Gastroenterology

Urology

Pulmonology

Ear, Nose, and Throat (ENT)

Gynecology

Orthopedics

By Procedure Type:

Diagnostic

Therapeutic

Screening

By Endoscope Type:

Colonoscopes

Gastroscopes

Bronchoscopes

Cystoscopes

Hysteroscopes

Nasopharyngoscopes

Others

By End User:

Hospitals

Ambulatory Surgery Centers (ASCs)

Clinics

By Material:

Disposable Fiber Optics

Video Endoscopes

Others

By Region

North America

US

Canada

Mexico

Europe

Germany

France

UK.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/single-use-flexible-endoscope-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[bommagoni]

Endoscope Reprocessing Devices Market Share, Growth, Forecast

[globalinsightsservices]

Endoscopy Devices Market Competitive Analysis and Forecast 2023-2033

Market Definition

An endoscopy is a medical procedure that involves inserting a thin, flexible tube called an endoscope into the body. The endoscope is equipped with a light and a camera, which allows the doctor to see inside the body. Endoscopy is used to diagnose and treat a variety of conditions.

Market Outlook

There are several key trends in endoscopy devices technology.

One is the miniaturization of endoscopes. This has led to the development of new, smaller devices that can be used for a variety of procedures.

Another trend is the use of new imaging technologies, such as 3D imaging, that provide more detailed images of the inside of the body.

There is also a trend towards the use of more sophisticated devices that can be controlled remotely, which allows for more precise procedures.

The main drivers of the endoscopy devices market are the increasing prevalence of gastrointestinal diseases, the growing geriatric population, the rising number of minimally invasive surgical procedures, and the increasing adoption of endoscopy devices.

The rising prevalence of gastrointestinal diseases is one of the key drivers of the endoscopy devices market. The rising prevalence of gastrointestinal diseases is attributable to the growing geriatric population, the changing lifestyle, and the increasing incidence of obesity.

The growing geriatric population is another key driver of the endoscopy devices market. The elderly population is more susceptible to gastrointestinal diseases.

The rising number of minimally invasive surgical procedures is another key driver of the endoscopy devices market. Minimally invasive surgery is associated with shorter hospital stays, less pain, and faster recovery times.

The increasing adoption of endoscopy devices is another key driver of the endoscopy devices market. Endoscopy is a minimally invasive procedure that allows the visualization of the digestive tract.

To Know More: https://www.globalinsightservices.com/reports/endoscopy-devices-market/

Research Objectives

Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region

Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling

Identify factors influencing market growth and challenges, opportunities, drivers and restraints

Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates

Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities

Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market

To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.

Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives

Request Sample: https://www.globalinsightservices.com/request-sample/GIS21225/

Market Segments

The Endoscopy Devices Market is segmented by  product, hygiene, application, end user, and region. On the basis of product, the market is categorized into endoscope, mechanical endoscopic equipment, accessories, and other endoscopy equipment. On the basis of hygiene, the market is segmented into single-use, reprocessing, and sterilization. By application, it is classified into bronchoscopy, arthroscopy, laparoscopy, and others. By end user, it is segmented into hospitals, ambulatory surgery centers & clinics, and others. Region-wise the market is divided into North America, Europe, Asia-Pacific, and the Rest of the World.

Request Customization: https://www.globalinsightservices.com/request-customization/GIS21225/

Key Players

The Endoscopy Devices Market includes players such as  HOYA Corporation, Olympus Corporation, Stryker Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, CONMED Corporation, Medtronic Plc, Karl Storz GmbH & Co. KG, Johnson & Johnson, and Medrobotics Corporation.

Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS21225/

Research Scope

Scope – Highlights, Trends, Insights. Attractiveness, Forecast

Market Sizing ��� Product Type, End User, Offering Type, Technology, Region, Country, Others

Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain

Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments

Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis

Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.

[market-data-forecast]

The Global Infection Control Market: Poised for Steady Growth

The global infection control market is projected to reach $58.3 billion by 2027, growing at a compound annual growth rate (CAGR) of 3.1% from 2022 to 2027, according to a new industry report. Rising incidence of hospital-acquired infections, growth in the healthcare industry, and increasing adoption of sterilization and disinfection products and services are key factors driving growth.

To know about the assumptions considered for the study, Request for Free Sample Report

Hospital-acquired infections (HAIs) remain a major concern worldwide, being a leading cause of morbidity and mortality. More than half of HAIs are associated with the use of medical devices such as catheters and ventilators. This is spurring demand for effective infection control measures in healthcare settings including sterilization of medical equipment and disinfection of surfaces.

The report identifies sterilization products and services as the largest segment of the infection control market. This includes equipment like autoclaves and ethylene oxide sterilizers, contract sterilization services, and consumables such as sterilization indicators. The move towards outsourcing sterilization by hospitals and pharmaceutical companies is expected to drive growth in contract sterilization services.

Protective barriers including medical nonwovens, face masks, and gloves represent another key segment. The COVID-19 pandemic led to skyrocketing demand for personal protective equipment (PPE) to minimize disease transmission. While PPE demand may normalize post-pandemic, the importance of protective barriers is now firmly established.

Hospitals and clinics are the dominant end user segment as HAIs primarily originate in healthcare settings. However, medical device companies are also major users of sterilization services and infection control products. Geographically, North America holds the largest market share, fueled by high healthcare spending, stringent regulations, and advanced facilities in the region.

Key players in infection control include Steris, Getinge, Ecolab, 3M, and Sotera Health. These companies are focused on new product development and mergers and acquisitions to expand their portfolio.

For instance, in 2021 Steris acquired Cantel Medical, a major provider of infection prevention products and services. The deal allowed Steris to diversify beyond sterilization into other areas of infection control including endoscope reprocessing.

The use of alternative sterilization technologies is an emerging trend in this market. For example, companies are developing low-temperature hydrogen peroxide sterilizers as an alternative to ethylene oxide, which faces environmental and health concerns. Automated UV disinfection devices are also gaining interest as a greener alternative to manual chemical disinfection.

To know about the assumptions considered for the study, download the pdf brochure

Overall, the global infection control market appears poised for steady growth driven by rising healthcare expenditure, focus on combating HAIs, and innovation by leading players. Stringent regulations and guidelines will also compel healthcare providers to adopt sterilization and disinfection best practices. However, the market faces restraints such as the environmental impact of certain chemicals and the high costs involved in maintaining rigorous infection control.

Going forward, companies need to develop newer disinfectants and sterilants with a better safety profile. Leveraging technologies like robotics and artificial intelligence to automate reprocessing workflows can also enhance quality and free up staff time. Patient education on infection prevention and antimicrobial stewardship will be equally crucial. Effective infection control ultimately requires a holistic approach spanning new technologies, best practices, and behavioral changes. With healthcare systems prioritizing patient safety like never before, the infection control market looks set to flourish.

[morerushikesh]

All information provided in the report is derived from trusted industrial sources. Endoscope Reprocessing Device Market research reports find market figures between 2020 and 2024. The market will exhibit remarkable CAGRs in the aforementioned period.

[coldpenguintaco]

Endoscope Reprocessing Device Market to Reach US$ 2,171.5 Mn by 2027

Endoscope Reprocessing Device Market to Reach US$ 2,171.5 Mn by 2027

Global endoscope reprocessing device market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by growing geriatric population, increasing number of Endoscope surgeries and development of automated endoscope reprocessor and techniques. According to the new report, “Endoscope Reprocessing Device Market: Global Industry Analysis…

[healthcaremarketfmi]

Disposable Endoscopes Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2032

As per Future Market Insights’ latest analysis, valuation of the global disposable endoscopes market was around US$ 909.9 Million in 2021. The market is projected to exhibit a CAGR of close to 17.6% from 2022 to 2032 and reach an estimated valuation of around US$ 5.3 Billion in 2032.

Endoscope-related infections can be differentiated into endogenous and exogenous. Presence of microbes that have the ability to form biofilms or adhere to medical devices can possess the ability to cause cross-contamination in healthcare settings. Hence, disposable endoscopes are a better option that allows healthcare facilities to skip the steps of reprocessing and also reduce the chances of acquiring infections. Between 2019 and 2020, in the U.S., there was a 24% increase in central line-associated bloodstream infection (CLABSI), with the largest increase observed in ICU (50%), as per the Centers for Disease Control and Prevention (CDC).

Growing investments in research and development activities & healthcare settings to develop novel products with an emphasis on low-cost product offerings and lesser infection exposure, are also expected to propel the disposable endoscopes market during the forecast period. Emerging startups are focusing on improving features of endoscopes to attract more customers.

The use of ultra-thin polymer fiber allows reaching anatomical sites that were formerly unreachable. Increasing preference among physicians and patients for the detection of cancer & tumors and reducing the risk of infection due to the safety and efficacy of endoscopic procedures would also favor growth in the disposable endoscopes market.

In August 2021, for instance, a customized peregrine endoscope from 3NT was launched to provide clinicians with a close-up view of the difficult-to-reach regions with sinuses to aid in the diagnosis and treatment of conditions, including polyps and cancer.

Key Takeaways: Disposable Endoscopes Market

Disposable bronchoscopes are the leading product type and held approximately 30.1% of the global market share in 2021.

By end user, hospitals are dominating the global disposable endoscopes market and are expected to exhibit a CAGR of 17.5% during the forecast period.

China is one of the leading manufacturers of disposable endoscopes and it held a market share of around 6.7% in 2021.

Germany exhibited a share of around 7.5% in the Europe disposable endoscopes market in 2021.

North America is considered to be the leading region and held a share of 36.8% in 2021.

For More Information : https://www.futuremarketinsights.com/reports/disposable-endoscopes-market

“Growing emphasis on technological advancement and development of cost-effective disposable medical equipment are set to propel sales of disposable endoscopes across the globe,” says an analyst of Future Market Insights.

Competitive Landscape: Disposable Endoscopes Market

The market for disposable endoscopes is highly fragmented with the presence of several local, emerging, as well as established players. Key players are focusing on new product launches with additional features, obtaining regulatory approvals, and increasing their manufacturing capabilities to compete with their rivals.

For instance,

In April 2022, Ambu launched a single-use endoscope and accompanying mA scope, known as Ascope 4 Rhinolaryngo Slim and Aview 2 Advance HD monitor, which would enable fiberoptic endoscopic evaluation of swallowing.

In May 2021, Boston Scientific Corporation attained CE approval for its EXALT Model B. It is a single-use bronchoscope, a device made for bedside operations in the ICU and operating room.

[pranjaldalvi]

Disposable Endoscopes Market Insights: Innovation, Demand Drivers, and Growth Potential

The disposable endoscopes market has witnessed robust growth in recent years, propelled by increased demand for infection control, technological advancements, and the growing preference for cost-effective medical solutions. With hospitals and healthcare systems under constant pressure to minimize cross-contamination risks and reduce reprocessing costs, disposable endoscopes are becoming a preferred alternative to traditional reusable ones.

Market Overview

Disposable endoscopes are single-use medical devices designed to perform diagnostic or therapeutic procedures without the need for cleaning or sterilization. They eliminate the risks associated with endoscope reprocessing, including infection transmission and equipment damage. This has made them particularly valuable in settings like emergency departments, intensive care units, and outpatient centers where efficiency and safety are paramount.

The global disposable endoscopes market was valued at approximately USD 1.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of over 15% through 2030. This surge is driven by both the growing need for infection control and the rapid adoption of minimally invasive procedures.

Key Market Drivers

1. Infection Control and Patient Safety

One of the primary drivers of growth is the heightened focus on infection prevention. Reusable endoscopes have historically been linked to outbreaks of hospital-acquired infections due to improper sterilization. Disposable endoscopes significantly reduce this risk, making them a safer alternative in many clinical scenarios. Regulatory bodies like the CDC and FDA have highlighted the importance of improving endoscope hygiene, further propelling the shift toward disposable devices.

2. Cost and Operational Efficiency

Though initially more expensive on a per-unit basis, disposable endoscopes can prove more cost-effective when considering the total cost of ownership. This includes expenses associated with cleaning, reprocessing, repairs, storage, and labor. Smaller clinics and ambulatory surgical centers especially benefit from disposable options, as they often lack the infrastructure required for complex reprocessing workflows.

3. Technological Advancements

Modern disposable endoscopes now feature high-resolution imaging, improved maneuverability, and wireless or connected capabilities, narrowing the performance gap between reusable and disposable models. Companies are investing heavily in R&D to enhance the clinical utility and functionality of these devices, increasing their adoption across a range of specialties including bronchoscopy, urology, and gastrointestinal procedures.

4. Growing Demand for Outpatient and Minimally Invasive Procedures

The global healthcare trend toward outpatient care and minimally invasive interventions has accelerated the demand for compact, efficient, and low-risk devices. Disposable endoscopes cater perfectly to this need by reducing turnaround time between patients and enhancing workflow efficiency.

Regional Insights

North America holds the largest share of the disposable endoscopes market, owing to its advanced healthcare infrastructure, high healthcare spending, and favorable reimbursement policies. The United States, in particular, is a frontrunner due to its proactive stance on infection control.

Europe is also witnessing steady growth, driven by regulatory support and increasing awareness among clinicians regarding infection risks. However, budget constraints in public health systems can limit rapid adoption.

Asia-Pacific is emerging as a high-growth region, fueled by a rising population, increasing investments in healthcare, and growing awareness of patient safety. China, India, and Japan are leading markets in this region, with both public and private players expanding their endoscopic capabilities.

Competitive Landscape

The disposable endoscopes market is moderately consolidated, with major players including Ambu A/S, Boston Scientific Corporation, Olympus Corporation, and Karl Storz. These companies are focused on product innovation, partnerships, and geographic expansion to gain a competitive edge.

Startups and mid-sized firms are also entering the market, offering cost-effective solutions and targeting niche segments. The increasing number of players is likely to foster competition and drive innovation.

Market Challenges

Despite its advantages, the disposable endoscopes market faces several challenges:

Environmental Concerns: The single-use nature of these devices raises sustainability issues. Healthcare providers and manufacturers are under pressure to develop eco-friendly solutions, including recyclable or biodegradable materials.

Cost Perception: While the overall cost may be lower in some settings, the upfront per-use cost can be a deterrent for healthcare systems with tight budgets.

Training and Integration: Transitioning to disposable devices requires changes in clinical workflow, which may be met with resistance from staff accustomed to reusable instruments.

Future Outlook

The future of the disposable endoscopes market looks promising, with continued innovation expected in areas such as wireless data transmission, AI-assisted diagnostics, and more robust environmental solutions. As infection control remains a top priority and healthcare systems strive for efficiency, disposable endoscopes are poised to become a staple in modern medical practice.

[reportsneww]

Infection Control Market size 2023 to 2031

Newark, New Castle, USA - Growth Plus Reports' most recent study examines the Global Infection Control Market's production, prospective uses, demand, key companies, and SWOT analysis.

The Infection Control Market Report will help you determine the best distribution strategies for specific products and identify potential markets. In addition, the report examines the purchasing and supply patterns that impact the market. The Infection Control market research report provides insights into the limitations, market trends, prospects, drivers, and competition in the Infection Control sector.

You may get insights into the TOC, and Statistics for essential facts, information, trends, and competitive landscape information.

Download Free Sample Report Now @ https://www.growthplusreports.com/inquiry/request-sample/infection-control-market/8187

The following are the leading companies in the Global Infection Control market:

3M Company

Belimed AG

Halyard Health, Inc.

Getinge Group

Cantel Medical Corporation

Advanced Sterilization Products

Matchana Group

Reckitt Benckiser

Sterigenics International

MMM Group

Honeywell International, Inc.

Cantel Medical Corporation

STERIS Corporation

Ecolab

Growth Plus Reports studies the key trends in each category and sub-segment of the Infection Control market, along with Global and regional projections from 2023 to 2031. Our research splits the market into product type and application segments.

SEGMENTATION

GLOBAL INFECTION CONTROL MARKET - ANALYSIS & FORECAST, BY PRODUCT 

Sterilization

Steam

Radiation

Sterilant

Indicators

Disinfection

Washers

UV Disinfection

Disinfectants

Endoscope Reprocessing

Protective Barriers

GLOBAL INFECTION CONTROL MARKET - ANALYSIS & FORECAST, BY END-USER

 Hospitals & Clinics

Pharmaceutical & Medical Device Companies

Others

For More Information or Query or Customization visit: https://www.growthplusreports.com/inquiry/customization/infection-control-market/8187

Companies may utilize Infection Control market report to get insights on market variables and any restraints that may affect the manufacturing of their product. Companies that are expanding abroad require thorough Global market research that includes real market data to assist with their marketing strategy. This Global market Infection Control industry study analyzes important market dynamics and provides in-depth information and statistics to help companies flourish. This research report on the Infection Control market takes advantage of advanced and professional approaches such as SWOT analysis and GRG Health's unique GrowthMIX strategy.

This report is useful in addressing various essential issues for market participants, while also supporting them in making investments and leveraging the market opportunities.

Infection Control Market TOC: https://www.growthplusreports.com/report/toc/infection-control-market/8187

Market segment by Region/Country including: –

-North America (United States, Canada and Mexico) -Europe (Germany, UK, France, Italy, Russia and Spain etc.) -Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) -South America (Brazil, Argentina and Colombia etc.) -Middle East and Africa (South Africa, UAE and Saudi Arabia etc.)

QUICK BUY: https://www.growthplusreports.com/checkout-8187

Browse Latest Healthcare Reports:

Aortic Valve Replacement Devices Market Industry Analysis report to 2031

Gastrostomy Tube Feeding Devices Market Size, Share & growth report to 2031

Bioabsorbable Stents Market Size, Share, growth & Trends to 2031

Peripheral Nerve Repair Market Size, Share, Demand & Trends to 2031 

PARP Inhibitors Market Size, Share & Trends to 2031 

Central Venous Catheters Market size, share & growth 2031 

Aortic Valve Replacement Devices Market Industry Analysis report to 2031

Bioabsorbable Stents Market Size, Share, growth & Trends to 2031 Peripheral Nerve Repair Market Size, Share, Demand & Trends to 2031

Gastrostomy Tube Feeding Devices Market Size, Share & growth report to 2031

PARP Inhibitors Market Size, Share & Trends to 2031

[impossibledeanmakerwombat]

Endoscope Reprocessing Device Market: Key Players, Applications, Outlook, SWOT Analysis And Forecasts to 2032

Robust expansion of biotechnology and pharmaceutical industries across emerging countries is expected to pave significant opportunities for the development and advancements in molecular biology enzymes, kits & reagents. In addition, accelerating adoption of personalized medicines will further boost demand for molecular biology enzymes, kits & reagents. The molecular biology enzymes kits reagents market is predicted to grow at a 15.8% CAGR through 2032.

Adoption of these enzymes and their kits & reagents is expected to witness proliferation with technological advancements dedicated toward the development of innovative and more efficient products, in tandem with surging research and development investments being made by leading pharmaceutical and biotechnology companies.Very recently, there has been an increase in the occurrence of genetic illnesses, which has prompted more people to use molecular diagnostics. Epigenetics and polymerase chain reaction (PCR), two crucial molecular diagnostics procedures, call for molecular biology enzymes, kits, and reagents. The demand for these enzymes and kits & reagents is anticipated to significantly increase in the near future due to rising genetic disorder occurrences and an ageing population.

Future Market Insights has published a new comprehensive research report titled, “Molecular Biology Enzymes, Kits & Reagents Market: Global Industry Analysis (2012-2016) & Opportunity Assessment (2017-2026)”. The report covers present market scenario as well as imparts future growth prospects of the molecular biology enzymes, kits & reagents market for the period between 2017 and 2026.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6385

The report also engulfs key drivers, hindrances, opportunities and trends that are affecting expansion of the global molecular biology enzymes, kits & reagents market. The report offers an overall picture of the global molecular biology enzymes, kits & reagents market, in order to help businesses seeking opportunities for making investments in the market.

Structure of the Report

The report provides an exhaustive synopsis of the global molecular biology enzymes, kits & reagents market, engulfing an executive summary that elucidates the core trends influencing the market expansion. This chapter also sheds light on impacts that the dynamics are likely to pose on growth of the market in the long run. The report also imparts figures appertaining to CAGRs from a historical and forecast point of view. An overview of the global molecular biology enzymes, kits & reagents market follows the executive summary, and issues a clear picture of the market’s scope to the report readers.

The overview includes a concise market introduction succeeded by a formal definition of “molecular biology enzymes, kits & reagents”. Chapters subsequent to the overview elaborates several dynamics including driving factors, limitations and prospects being observed in the market through the forecast period. Meanwhile these chapter also inundate detailed insights related to the bottom line of enterprises, global economy and fiscal stimulus.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-6385

Market Taxonomy

A segmentation analysis offered in the report propounds forecasts on global molecular biology enzymes, kits & reagents market. Categorizing the market in terms of application, end-user, product type, and region. Analysis on Y-o-Y growth comparison, the market share comparison, and the revenue comparison coupled with relevant market numbers is offered in this chapter. Global market for molecular biology enzymes, kits & reagents has been regionally divided into Japan, Middle East & Africa, Europe, Asia-Pacific excluding Japan, North America, and Latin America.

Region

North America

Latin America

Europe

Japan

APEJ

MEA

Product Type

Kits & Reagents

Modifying Enzymes

Restriction Enzymes

Other Product Types

End User

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostic Centers

Academic and Research Institutes

Other End Users

Application

Sequencing

Cloning

Polymerase Chain Reaction

Restriction Digestion

Synthetic Biology

Epigenetics

Other

Competition Landscape

This analytical research report on the global molecular biology enzymes, kits & reagents market is a complete package, which includes intelligence on key participants underpinning the market expansion. In the last chapter of the report, which elucidates the competitive scenario of the market, strategies implemented by the market players, along with their product overview, company overview, key financials, key developments and SWOT analysis has been rendered exhaustively. In addition, region-wide spread of these market players, their future expansion plans, market shares, revenues, and mergers & acquisition activities between them have been described in detail in this concluding chapter of the report. An intensity map has been employed in the report to profile the market players situated across geographies.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-6385

Research Methodology

Credibility of the researched statistics and data is backed by the unique research methodology employed by the analysts at FMI, which ensures higher accuracy. FMI’s research report on the global molecular biology enzymes, kits & reagents market can assist its readers in gaining detailed insights on many different aspects governing the market around key regional segments included in the report.

The report readers can further slate key strategies for tapping into vital revenue pockets and gaining benefits over the intensifying competition in the market. Information presented in the report has been scrutinized and monitored thoroughly by FMI’s industry experts. Figures and numbers offered in the report have also been validated by the analysts in order to facilitate strategic decision making for the report readers.

[market-insider]

Increasing Incidence Of Infection Due To Reusable Endoscopes Driving The North America Disposable Endoscopes Market

The North America disposable endoscopes market size is expected to reach USD 2.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2022 to 2030. Increasing incidence of infection due to reusable endoscopes in the hospitals and the growing preference for disposable endoscope components are some of the major factors anticipated to drive the market growth over the forecast years. In addition, cleaning and disinfecting disposable endoscopes and their accessories to eliminate the disease transmission risk is a very tedious task for medical professionals.

The increasing number of endoscopic procedures and the growing prevalence of several chronic diseases are also further expected to accelerate the market growth. The lack of reprocessing and drying practices by the medical staff increases the chance of contamination which in turn drives the single-use endoscopes adoption. For instance, the data published in the American Journal of Infection Control stated that about 71% of the reusable endoscopes sample found microbial growth. The bronchoscopy segment dominated the market by application in 2021 with a revenue share of 29.3%. Flexible bronchoscopes play a critical role in the therapeutic and diagnostic management of several pulmonary disorders and better procedural outcomes.

Gain deeper insights on the market and receive your free copy with TOC now @: North America Disposable Endoscopes Market Report

The growing adoption of bronchoscopes for the diagnosis of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is expected to drive the segment growth. Increasing COVID-19 cases and the fear of disease transmission due to the use of reusable bronchoscopes also boosted the single-use bronchoscope adoption. For instance, according to World Health Organization (WHO), the number of COVID-19 cases has increased to over 74.8 million by February 2022 in the United States of America. The hospital segment dominated the market and accounted for a revenue share of 47.5% in 2021 owing to the increasing number of endoscopic procedures performed in the hospitals and growing patient preference to visit the hospital for disease diagnosis.

However, the fastest growth is expected from the clinics segment over the forecast period owing to the increasing preference to use single-use endoscopic devices to reduce the risk of contamination, lower the procedure cost, and better clinical outcomes. In addition, an increasing number of clinics that performed endoscopic procedures in the U.S also anticipated supporting high growth of the segment. The COVID-19 pandemic has positively impacted the growth of the market. The benefit of using a disposable endoscope to minimize the risk of disease transmission increased its adoption during the COVID-19 period.

Increasing regulatory approval and strategic initiatives by the manufacturers to innovate new endoscopic devices to meet the consumer's needs, in turn, supported the growth of the market. For instance, in July 2020 a medical device manufacturer, Ambu Inc., got U.S. FDA 510(k) approval for its sterile single-use duodenoscope device. The device includes “aScope Duodeno” which is a single-use endoscope and “aBox Duodeno" a reusable processor unit to treat and diagnose several disease conditions like cancer, tumors, pancreatitis, and gallstones, in the bile duct and pancreas.

[meditech-insights]

Global Gastrointestinal Devices MedTech Market valued at $13–14 billion in 2021 and is expected to grow at a CAGR of 5% by 2026

The growth of the Gastrointestinal Devices MedTech market is being driven by an ageing population, an increase in GI procedures, an increase in cases of colorectal cancer, and screening requirements in many healthcare systems. Growing robotics use and focus to AI are providing further momentum for market expansion.

Global Gastrointestinal Devices MedTech market pegged at $13-14 billion in 2021, growing at a rate of 5%. Increased usage of single-use endoscopes, robots, and an increasing focus on AI in surgeries will be the main drivers of market expansion.

Medi-Tech Insights’ latest research report on Gastrointestinal Devices MedTech market analyses the worldwide market with respect to product and geography.

The Gastrointestinal Devices MedTech market is divided into four product-specific segments: GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic devices. It is evident from our research and interviews with industry professionals that the largest product segment is GI endoscopes. Within endoscope market, reusable endoscopes form major chunk of the market, owing to the fact that they are high-cost capital equipment with relatively greater adoption. However, single-use endoscope market is anticipated to expand more quickly. Shift driven by relatively lower acquisition cost, lower level of training & skills, no reprocessing cost and no risk of cross-contamination. Ambu and Boston Scientific are two major companies that offer single-use endoscopes.

“Currently, penetration of single-use endoscopes in GI is <5%. It is expected to increase to 10-15% in the next 5 years.”- CEO, Leading Gastrointestinal MedTech Company

Geographic Snapshot: Gastrointestinal Devices MedTech Market

Comprehensive regional and country-level assessment of the global Gastrointestinal Devices MedTech market covering U.S., Europe, Asia-Pacific and Rest of the World indicates that the U.S. is likely to dominate the market over the next five years while China will grow faster than other geographic areas.

Explore Premium Report on Gastrointestinal Devices MedTech Market @ https://meditechinsights.com/gastrointestinal-devices-medtech-market/

Gastrointestinal Devices MedTech market benefits from presence of large players like Olympus and Boston Scientific (BSX) but number of start-up companies have emerged especially in AI, single-use instruments

Four significant market segments are GI endoscopes, endotherapy devices, laparoscopes, and laparoscopic equipment. The top 3 endoscope companies are Olympus, Fujifilm, and Hoya with Olympus alone accounting for major chunk. Endotherapy devices is the fastest increasing market segment and is dominated by BSX with more than 50% market share. Laparoscope’s market is dominated by Stryker, Karl Storz, and Olympus. On the other hand, top 5 players accounted for more than 70% share of laparoscopic devices market.

Artificial intelligence (AI) and single-use endoscopy have attracted PE investment recently

Traditional endoscopy has a long history in healthcare, however the images produced by the procedure are assessed by clinicians, which might result in a wide range of interpretations. However, AI-assisted endoscopy is perceived to have potential to provide consistent results and improve patient care owing to which PEs are investing in AI providers. For instance, in August 2021, Iterative Scopes raised $30 mi Series A Financing to Advance AI-Driven Precision Medicine for Gastroenterology. Similar to this, single-use endoscopy is expected to be a priority area in the next years as major players have already begun to include them to their portfolios. Also, smaller/niche players are receiving funding. For instance, in October 2021, IQ endoscope received £4 mi (~$5 mi) for supporting regulatory approval process for its single use flexible gastroscope, as well as accelerating the development of its single use flexible colonoscope.

For More Detailed Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com